1. Temporal Variation in Soluble Human Leukocyte Antigen-G (sHLA-G) and Pregnancy-Associated Plasma Protein A (PAPP-A) in Pregnancies Complicated by Gestational Diabetes Mellitus and in Controls
- Author
-
Elisabetta Lovati, Fausta Beneventi, Riccardo Albertini, Elena Locatelli, Giulia Garbin, Arsenio Spinillo, Emilia Genini, C. Badulli, Carmine Tinelli, Miryam Martinetti, Chiara Cavagnoli, and Margherita Simonetta
- Subjects
Adult ,medicine.medical_specialty ,endocrine system diseases ,Pregnancy-associated plasma protein A ,Immunology ,Human leukocyte antigen ,Pregnancy ,Internal medicine ,Retrospective analysis ,Humans ,Pregnancy-Associated Plasma Protein-A ,Immunology and Allergy ,Medicine ,Prospective Studies ,Prospective cohort study ,Retrospective Studies ,HLA-G Antigens ,business.industry ,nutritional and metabolic diseases ,Obstetrics and Gynecology ,medicine.disease ,Blood proteins ,Gestational diabetes ,Diabetes, Gestational ,Pregnancy Trimester, First ,Endocrinology ,Reproductive Medicine ,Case-Control Studies ,Gestation ,Female ,business ,Biomarkers - Abstract
Problem To target gestational diabetes mellitus (GDM) by means of temporal variation in pregnancy-associated plasma protein A (PAPP-A) and soluble human leukocyte antigen-G (sHLA-G). Method of study Retrospective analysis of PAPP-A and sHLA-G blood levels in historical samples of 112 GDM and 112 controls, drawn at first trimester, and prospective study in 18 GDM and 105 controls collected in triplicate along the pregnancy. Six hundred and sixty-five samples were analyzed. Results Gestational diabetes mellitus had significantly lower first-trimester PAPP-A concentrations than controls (2343 ± 1519 versus 2996 ± 1955 mU/mL, in retrospective brunch and 2490.57 ± 1828.52 versus 3240.84 ± 1930.69 mU/L in prospective one, P
- Published
- 2014
- Full Text
- View/download PDF